United States

Mallinckrodt Plc

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States

Post An Enquiry

Virtual Booth

Virtual Innovation Day

Participation Not Confirmed

Update your events

Mallinckrodt Gets FDA Nod for Strata Graft Thermal Burn Treatment

Lead Product(s): Allogeneic Cultured Keratinocytes Dermal Fibroblasts Murine Collagen-dsat

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: StrataGraft

Highest Development Status: Approved Product Type: Cell and Gene therapy

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable June 15, 2021

Details:

StrataGraft is a bioengineered, allogeneic, "cellularized scaffold product" developed from keratinocytes grown on gelled collagen that contain dermal fibroblasts.

Pharmazz

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

United States

Post An Enquiry

Virtual Booth

Virtual Innovation Day

Participation Not Confirmed

Update your events

Resuscitative Effect of Centhaquine (Lyfaquin®) in Hypovolemic Shock Patients: A Randomized, Multicentric, Controlled Trial

Lead Product(s): Centhaquine

Therapeutic Area: Trauma (Emergency, Injury, Surgery) Product Name: Lyfaquin

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable May 10, 2021

Details:

Lyfaquin® is a frontline therapy used in conjunction with the standard of care and is well-positioned to address critical unmet needs in hypovolemic shock. The Company is marketing Centhaquine Citrate, with the brand name Lyfaquin® to health care professionals in India.